Community Research and Development Information Service - CORDIS

  • European Commission
  • CORDIS
  • Projects and Results
  • Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system.

Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system.

From 2015-07-01 to 2016-12-31, closed project

Project details

Total cost:

EUR 150 000

EU contribution:

EUR 150 000

Coordinated in:

Spain

Call for proposal:

ERC-2014-PoCSee other projects for this call

Funding scheme:

ERC-POC - Proof of Concept Grant

Objective

Host Institution

FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON
Spain

EU contribution: EUR 150 000


CALLE NAZARET 115-117
08035 BARCELONA
Spain
Activity type: Research Organisations

Beneficiaries

FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON
Spain

EU contribution: EUR 150 000


CALLE NAZARET 115-117
08035 BARCELONA
Spain
Activity type: Research Organisations

To know more

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top